Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK
The release of an active drug from the prodrug generates a pro-fragment that typically has no biological activity and could result in adverse effects. By combining two drugs, wherein each drug acts as a pro-fragment of the other drug will eliminate the pr
Rana, Sandeep,Kour, Smit,Sonawane, Yogesh A.,Robb, Caroline M.,Contreras, Jacob I.,Kizhake, Smitha,Zahid, Muhammad,Karpf, Adam R.,Natarajan, Amarnath